Transactions based on a high level of ethics are required at every stage of Sysmex’s operations̶from research and development to manufacturing, sales, and after sales support̶as the number of opportunities for collaboration with medical institutions and medical professionals is increasing.
In Japan, Sysmex Corporation and Sysmex International Reagents, which are members of the Japan Association of Clinical Reagents Industries, concur with the philosophy outlined in the association’s “Guidelines on Transparency of Relationships between Corporate Activities and Medical Institutions”, and they disclose information related to funding provided to such institutions.
Overseas, Sunshine Acts, which require companies to ensure transparency in their relations with healthcare institutions, have been enacted in the United States, France, etc. We report and disclose information about relevant funds for healthcare institutions to government authorities in the countries in which we operate. We upload the information to our website, and it has also been published on the websites of these authorities.